Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.

Following 10 days of compound treatment, the steady-state levels of the apoE receptors LDLR and VLDLR appeared reduced when compared to that of vehicle controls, but these differences did not reach statistical significance (Figure 4B ).

also in 111,027 other papers